Biotech | November 02, 2021
AstraZeneca to transfer global rights for Eklira and Duaklir to Covis Pharma
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The Board of Directors of Caplin Point Laboratories at its meeting have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Lyka Labs has reported consolidated financial results for the period ended September 30, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
